Kratom -- The Latest Thinking on this Herb from Dr. McCurdy
Here is a new article, just published yesterday, that may signal a possible future direction in the legal path of the herb, kratom.
Actually, there were hints that turning the rough natural herb -- a varied mixture of perhaps 40 different alkaloids -- into a standardized, laboratory-processed product in order to persuade the FDA to stop raising objections to kratom's legality back in 2016, when we at the American Kratom Association were fighting to keep the U.S. Drug Enforcement Agency from placing it in Schedule 1 and off-limits to the growing number of Americans.
Ironically, this effort to ban kratom came during the height of the U.S. struggle to reduce opioid drug addiction, with kratom being an inexpensive, legally-available product that was widely being used to wean opioid and other prescription drug users from pharmaceutical and illicit drugs.
It is very curious that, by contrast, the cannabis market in the United States, has taken a different approach. While the complex herbal marijuana is on sale at state regulated dispensaries for mostly medicinal use (and increasingly for recreational use), growers have been allowed to increase drastically the percentage of THC (the psychoactive alkaloid in cannabis) and decrease the levels of the CBD-related compounds to negligible levels.
It is amusing that cannabis has become a far-more intoxicating herb in its march toward becoming a nationally-accepted "drug of choice", while kratom -- which always struck me as having little psychoactive effects at moderate dosages -- now seems destined to eventually be "sanitized" in the laboratory by trying to remove the slight amounts of 7-hydroxymitragynine found in the natural herb.
It goes unmentioned in the above-linked article that, even if the more habit-forming alkaloid is removed (at some added expense for the consumer), the consumer's body can still turn the primary kratom alkaloid Mitragynine into 7-hydroxymitragynine!
Please support my sponsor, Christopher's Organic Botanicals, which provides consumers AKA-certified cGMP kratom, with each batch tested for Mitragynine, 7-Hydroxymitragynine, but also Speciogynine, and Paynantheine.
Sadly, to the best of my knowledge, there has so far been no research done on the possible use of kratom in its traditional application for helping to control blood sugars. With diabetes being so prevalent in the USA, this would seem to be another factor -- if proven in clinical testing -- to support the legality of this promising herb. (Ah, but first the pharmaceutical monopoly's objections would need to be overcome!)
Continue reading "Kratom -- The Latest Thinking on this Herb from Dr. McCurdy"